Literature DB >> 17079938

Can pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subjects with dyslipidemia?

Lucio Gullo1, Eugenio Salizzoni, Carla Serra, Lucia Calculli, Luciana Bastagli, Marina Migliori.   

Abstract

OBJECTIVE: It has been proposed by some investigators that benign pancreatic hyperenzymemia could result from pancreatic steatosis that they believe would have been caused by dyslipidemia; their diagnosis of steatosis was based on the finding of a hyperechogenic pancreas at ultrasound. The aim of this study was to assess the validity of this proposed model.
METHODS: The study group was composed of 18 subjects with benign pancreatic hyperenzymemia, 12 men and 6 women; mean age, 55 years; range, 38 to 68 years. All 18 had dyslipidemia and 9 had hyperechogenic pancreas at ultrasound. In addition, 6 subjects with benign pancreatic hyperenzymemia but who did not have dyslipidemia or hyperechogenic pancreas and 10 healthy subjects with none of these conditions were also studied as controls. In each of these subjects, magnetic resonance imaging of the pancreas was performed to assess the presence of pancreatic steatosis.
RESULTS: Magnetic resonance imaging showed normal pancreas with no signs of fatty infiltration in all 18 subjects with dyslipidemia, including those with both dyslipidemia and hyperechogenic pancreas at ultrasound. A similar result was found in all control subjects.
CONCLUSION: The finding of a completely normal pancreas at magnetic resonance imaging does not support the proposed model in which pancreatic hyperenzymemia in subjects with dyslipidemia is attributed to pancreatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079938     DOI: 10.1097/01.mpa.0000240603.26312.2a

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

Review 1.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

2.  Pancreatic cancer: risk and preventive factors.

Authors:  Anna Licata; Giuseppe Montalto; Maurizio Soresi
Journal:  Intern Emerg Med       Date:  2018-02-07       Impact factor: 3.397

3.  Pancreatic hyperechogenicity on endoscopic ultrasound examination.

Authors:  Yucel Ustundag; Guray Ceylan; Koray Hekimoglu
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

4.  Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.

Authors:  Jun Seok Lee; Sang Heum Kim; Dae Won Jun; Jee Hye Han; Eun Chul Jang; Ji Young Park; Byung Kwan Son; Seong Hwan Kim; Yoon Ju Jo; Young Sook Park; Yong Soo Kim
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

Review 5.  Significant elevations of serum lipase not caused by pancreatitis: a systematic review.

Authors:  Ahmer M Hameed; Vincent W T Lam; Henry C Pleass
Journal:  HPB (Oxford)       Date:  2014-06-03       Impact factor: 3.647

6.  Fat Tissue Infiltration into the Pancreas Parenchyme and Its Effect on the Result of Surgery.

Authors:  Sang Ho Yoon; Eung-Ho Cho; Sang Bum Kim; Sun-Hoo Park
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

Review 7.  Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.

Authors:  Roberto Catanzaro; Biagio Cuffari; Angelo Italia; Francesco Marotta
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.